When it comes to PPE, we could be better protecting our frontline health-care workers. We need to update current guidelines to reflect the latest evidence around how COVID-19 spreads.
The governments of several African countries have been reporting counts of confirmed cases, recoveries and deaths related to COVID-19, without a breakdown by age and sex.
Test positivity rates measure the success of a testing program. Even though the US performs a huge number of tests, high test positivity rates across the country show that that it still isn't enough.
COVID-19 tests rely on a process developed at a biotech company co-founded by a Canadian. Canada’s current testing expertise needs to be channelled to prepare for the next wave, and the next pandemic.
Whether a coronavirus vaccine involves a live virus or a carrier organism, it will probably require more than one injection. But that's not a bad thing.
Research shows that children can become infected with the coronavirus and spread it to others. Though rare, some kids do become severely ill and a few have died from COVID-19.
Many people are reporting persistent symptoms like headaches and shortness of breath after two months or more since being infected.
Ideally everyone could get tested frequently for the coronavirus. No state is close to achieving this, but some are doing better than others. What are the challenges in meeting demand for testing?
A new study not only shows that the malarial drug chloroquine doesn't block SARS-CoV-2 from infecting lung cells, but also explains why.
Healthcare workers bear the extraordinary practical and psychological challenges of working daily with the threat of infection and for many months.
The race is on to develop a vaccine for the COVID-19 coronavirus. Australian researchers are leading several major clinical trials that might help bring an end to the deadly disease.
A team of researchers from Indiana University performed random testing for SARS-CoV-2 across the state. The results offer some of the most accurate data to date about important aspects of the virus.
On a family camping trip over the Australia Day long weekend, I sat in a tent with my laptop, designing New South Wales’ first genomic sequencing test for COVID-19.
The experimental vaccine stimulates the creation of antibodies. Now we need to show that these effectively protect us from the coronavirus.
COVID-19 antibody tests can't replace the use of PCR tests in people showing symptoms. But they can help test people who may be infected and asymptomatic.
Scientists have developed and tested a new anti-clotting drug in mice that shows promise for treating heart attacks and stroke. It may also prove useful for COVID-19.
The percentage of people who die from a coronavirus infection is an important number for public health experts to know. Recent estimates now put it at 0.65%, far lower than initially thought.
As the pandemic drags on, uncertainty and fears about health and safety mix with confusion and challenges tied to re-opening society. You need flexibility when picking your coping strategies.
My international research project was put on hold – so I volunteered to become a COVID-19 tester. Here's what I learned.
Vaccine development usually spans a number of decades. This is because there's a need to understand the mechanisms of protection against the pathogen, and to minimise adverse reactions.